RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer

Gene

Volumn 531, Issue 1, 2013, Pages 112-116

  Zou, Yang ^a   Wang, Feng ^a   Liu, Fa Ying ^a   Huang, Mei Zhen ^b,c   Li, Wei ^a,c   Yuan, Xiao Qun ^a,c   Huang, Ou Ping ^b   He, Ming ^c  

^a Jiangxi Maternal and Child Health Hospital   (China)

^b Jiangxi Provincial Cancer Hospital   (China)

^c NANCHANG UNIVERSITY   (China)

Author keywords

Chinese; Mutation; Ovarian cancer; RNF43

Indexed keywords

DICER1 PROTEIN; DNA METHYLTRANSFERASE 3A; GENOMIC DNA; PPP2R1A PROTEIN; PROTEIN; RING FINGER PROTEIN; RNF43 PROTEIN; TRRAP PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; CHINESE; CLEAR CELL CARCINOMA; COLLOID CARCINOMA; DYSGERMINOMA; ENDOMETRIOID CARCINOMA; EXON; FEMALE; GENE MUTATION; GENETIC CONSERVATION; GRANULOSA CELL TUMOR; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OVARY CARCINOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; TERATOMA; YOLK SAC TUMOR;

A; ADENOSINE; ARG; ARGININE; ASP; ASPARTIC ACID; CATALOGUE OF SOMATIC MUTATIONS IN CANCER; CHINESE; COSMIC; DICER 1, RIBONUCLEASE TYPE III; DICER1; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 3 ALPHA; DNMT3A; FFPE; FORMALIN-FIXED, PARAFFIN-EMBEDDED; G; GUANOSINE; ILE; ISOLEUCINE; MUTATION; OVARIAN CANCER; PCR; POLYMERASE CHAIN REACTION; PPP2R1A; PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT A, ALPHA; RING FINGER PROTEIN 43; RNF43; SPSS; STATISTICAL PRODUCT AND SERVICE SOLUTIONS; TCGA; THE CANCER GENOME ATLAS; TRANSFORMATION/TRANSCRIPTION DOMAIN-ASSOCIATED PROTEIN; TRRAP; VAL; VALINE;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CHINA; DNA-BINDING PROTEINS; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS; OVARIAN NEOPLASMS; SEQUENCE ALIGNMENT; YOUNG ADULT;

EID: 84884818011     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.08.054     Document Type: Article

References (23)

1. Baker D.J., Jin F., Jeganathan K.B., van Deursen J.M. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 2009, 16:475-486.
2. Bast R.C., Hennessy B., Mills G.B. The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer 2009, 9:415-428.
3. Eitan R., et al. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol. Oncol. 2009, 114:253-259.
4. Furukawa T., et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci. Rep. 2011, 1:161.
5. Hagstrom S.A., Dryja T.P. Mitotic recombination map of 13cen-13q14 derived from an investigation of loss of heterozygosity in retinoblastomas. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2952-2957.
6. Hao H.X., et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 2012, 485:195-200.
7. Heravi-Moussavi A., et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N. Engl. J. Med. 2012, 366:234-242.
8. Koo B.K., et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 2012, 488:665-669.
9. Ley T.J., et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 2010, 363:2424-2433.
10. Long K.C., Kauff N.D. Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies. Curr. Opin. Oncol. 2011, 23:526-530.
11. Munkarah A., Chatterjee M., Tainsky M.A. Update on ovarian cancer screening. Curr. Opin. Obstet. Gynecol. 2007, 19:22-26.
12. Nagendra D.C., Burke J., Maxwell G.L., Risinger J.I. PPP2R1A mutations are common in the serous type of endometrial cancer. Mol. Carcinog. 2012, 10:826-831.
13. Ong C.K., et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat. Genet. 2012, 44:690-693.
14. Rossing M.A., Wicklund K.G., Cushing-Haugen K.L., Weiss N.S. Predictive value of symptoms for early detection of ovarian cancer. J. Natl Cancer Inst. 2010, 102:222-229.
15. Ryland G.L., et al. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J. Pathol. 2013, 229:469-476.
16. Shih IeM., et al. Somatic mutations of PPP2R1A in ovarian and uterine carcinomas. Am. J. Pathol. 2011, 178:1442-1447.
17. Sugiura T., Yamaguchi A., Miyamoto K. A cancer-associated RING finger protein, RNF43, is a ubiquitin ligase that interacts with a nuclear protein, HAP95. Exp. Cell Res. 2008, 314:1519-1528.
18. The Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615.
19. Visintin I., et al. Diagnostic markers for early detection of ovarian cancer. Clin. Cancer Res. 2008, 14:1065-1072.
20. Wei X., et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat. Genet. 2011, 43:442-446.
21. Wu J., et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:21188-21193.
22. Xing C., et al. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma. Mol. Cancer Ther. 2013, 12:94-103.
23. Yagyu R., Furukawa Y., Lin Y.M., Shimokawa T., Yamamura T., Nakamura Y. A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer. Int. J. Oncol. 2004, 25:1343-1348.